Berlin – September 08, 2026 -- PLAN-B NET ZERO AG and river-cleanup company everwave have tied clean-energy subscriptions directly to plastic removal, letting customers convert monthly add-on payments into a fixed volume of waste extracted from rivers before it reaches the ocean.

Schlieren – September 07, 2026 -- NovaGo Therapeutics AG has closed a Series B financing round of CHF 24 million ($30 million), led by Neurimmune and Pureos, to fund a proof-of-concept trial for its anti-Nogo-A antibody in acute spinal cord injury.

The equity round drew participation from existing and new investors and was supplemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life.

CHAM, Switzerland -- August 31, 2026 -- EYKON officially unveiled its new brand today, completing a separation from Landis+Gyr EMEA and establishing itself as an independent utility infrastructure technology company serving more than 75 markets.

The Swiss-based firm now supports over 100 million connected devices across the EMEA region, drawing on 130 years of utility-sector history rooted in Landis+Gyr's legacy operations.

CHAM, Switzerland -- -- EYKON unveiled its new corporate brand on Aug. 31, 2026, completing the separation of the former Landis+Gyr EMEA business into an independent utility infrastructure technology company. The Cham-based firm carries forward more than 130 years of Swiss utility engineering history under its new name. EYKON currently serves customers across more than 75 markets and supports over 100 million connected endpoints in the EMEA region.

Incheon, South Korea and Zug, Switzerland -- Samsung Biologics, through its Swiss subsidiary Samsung Peptide AG, published the formal tender offer prospectus for PolyPeptide Group AG, setting a cash price of CHF 44.31 per share and an implied equity value of approximately CHF 1.46 billion. The filing, made in Zug, Switzerland, follows a pre-announcement issued July 20, 2026, and covers all publicly held shares of the peptide-focused contract manufacturer listed on the SIX Swiss Exchange. The main acceptance period runs from Sept. 15 to Oct. 12, 2026.